Security record · archived quarter
VNDA
Vanda Pharmaceuticals Inc. · Healthcare · Biotechnology
15Tracked holders
0Δ holders
24.58MShares held
$116.00MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +7.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | 0 | 37.76M | $231.07M | +7 | −7 |
| Q1 2026 | 78 | +6 | 33.85M | $233.91M | +14 | −8 |
| Q4 2025 | 72 | -1 | 30.64M | $270.14M | +1 | −2 |
| Q3 2025 | 17 | 0 | 25.97M | $129.59M | — | −1 |
| Q2 2025 | 15 | 0 | 24.58M | $116.00M | — | — |
| Q1 2025 | 12 | 0 | 9.69M | $44.48M | — | — |
| Q4 2024 | 12 | +1 | 8.66M | $41.48M | +1 | — |
| Q3 2024 | 10 | -1 | 7.15M | $33.54M | — | −1 |
| Q2 2024 | 11 | — | 6.99M | $39.47M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 9.44M | — | $44.54M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passive) | 3.57M | — | $16.86M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passive) | 3.57M | — | $16.86M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passive) | 3.57M | — | $16.86M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passive) | 3.57M | — | $16.86M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 3.45M | -3.3% | $16.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Millennium Management ✦ | 3.12M | +45.8% | $14.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passive) | 1.69M | +4.8% | $7.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passive) | 1.69M | +4.8% | $7.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passive) | 1.27M | +1.1% | $5.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 526.87K | +200.0% | $2.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Marshall Wace ✦ | 471.72K | +945.9% | $2.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Marshall Wace ✦ | 471.72K | +945.9% | $2.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Marshall Wace ✦ | 471.72K | +945.9% | $2.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Wellington Management ✦ | 292.50K | +10.0% | $1.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 292.50K | +10.0% | $1.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 292.50K | +10.0% | $1.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 164.14K | -13.8% | $774,760 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 164.14K | -13.8% | $774,760 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 161.66K | — | $763,055 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 161.66K | — | $763,055 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 147.80K | -40.4% | $697,602 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 135.72K | +163.2% | $640,616 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 135.72K | +163.2% | $640,616 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 135.72K | +163.2% | $640,616 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 135.72K | +163.2% | $640,616 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Norges Bank ✦ (passive) | 115.00K | 0.0% | $542,800 | 0.0% | Held | 5 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 26.77K | 0.0% | $127,000 | 0.0% | Held | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 168 holders, 45.91M shares, $293.46M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API